Bank of New York Mellon Corp - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$117,563,000
+46.9%
680,307
-2.3%
0.03%
+47.6%
Q4 2014$80,028,000
-46.7%
696,265
-27.5%
0.02%
-48.8%
Q3 2014$150,069,000
-68.8%
960,514
-75.4%
0.04%
-36.9%
Q2 2014$481,160,000
+101.9%
3,900,780
+69.6%
0.06%0.0%
Q1 2014$238,311,000
-18.0%
2,300,077
-28.8%
0.06%
-19.8%
Q4 2013$290,489,000
-39.2%
3,229,802
-54.8%
0.08%
+12.5%
Q3 2013$477,450,000
+114.0%
7,138,912
+111.7%
0.07%
+2.9%
Q2 2013$223,057,0003,371,9680.07%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders